FDA Clearance Tracker · P230022-S004
Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel), Jewel P-WCD Firmware, Device Accessories Skin Preparati
Last checked: Nov 20, 2026Latest source record: Nov 19, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 19, 2025
Approved
Time to decision
20 days
Received Oct 30, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230022-S004
- Device name
- Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel), Jewel P-WCD Firmware, Device Accessories Skin Preparati
- Applicant
- Element Science, Inc.
- Applicant location
- Redwood City, CA
- Received
- Oct 30, 2025
- Decided
- Nov 19, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P230022
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P230022.
Source documents
Other decisions for Element Science, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P230022 · Decided Apr 30, 2025 · 667 days after receipt
Device type: Wearable automated external defibrillator (MVK) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.